Abstract
Crossed cerebellar diaschisis (CCD), known as a functional disconnection of the cerebellar hemisphere contralateral to a supratentorial lesion, is associated with poor clinical outcome but remains solely a radiologic diagnosis. [1] [2] [3] The subsequent reduction in both blood flow and oxygen extraction fraction in the affected cerebellar hemisphere is traditionally detected with ( 15 O)-H 2 O-PET. 2, [4] [5] [6] [7] [8] [9] Contemporary MRI techniques, such as dynamic susceptibility contrast MRI [10] [11] [12] and arterial spin labeling, 13, 14 however, may be favored because of better clinical accessibility and absence of exogenous radioisotopes.
In this regard, the application of blood oxygen leveldependent (BOLD) fMRI also deserves further investigation. From BOLD in combination with a carbon dioxide challenge, cerebrovascular reactivity (CVR) can be quantitatively mapped for the entire brain, including the cerebellum. [15] [16] [17] BOLD-CVR is defined as the percentage BOLD signal change per mm Hg carbon dioxide and is frequently used to measure supratentorial cerebrovascular reserve capacity. 18 Although BOLD signal changes can be seen in parallel with changes in cerebral blood flow, 19 the BOLD signal primarily depends on changes in deoxyhemoglobin-not cerebral blood flow changes directly. In participants with CCD, the presence of hypometabolism in the affected cerebellar hemisphere results in less oxyhemoglobin being converted to deoxyhemoglobin. This leads to less deoxyhemoglobin outwash after a physiologic cerebral blood flow increase (i.e., preserved cerebral blood flow reactivity in acetazolamide challenged PET imaging) and will subsequently lead to a dampened BOLD signal increase. 20, 21 Although a recent study 22 has demonstrated good feasibility of BOLD-CVR for detecting CCD, its diagnostic capacity and prognostic value remain to be studied in more detail. Therefore, our aim was to further investigate the role of BOLD-CVR for CCD.
Methods

Primary research question
Can BOLD-CVR identify CCD in patients with symptomatic unilateral cerebrovascular steno-occlusive disease?
Classification of evidence
This study provides Class II evidence that BOLD-CVR identifies CCD in patients with symptomatic unilateral cerebrovascular steno-occlusive disease.
Standard protocol approvals, registrations, and patient consents
The research ethics board of the canton Zurich, Switzerland (KEK-ZH-Nr. 2012-0427), approved the study, and all participants signed informed consent before participation.
Participant selection
Twenty-five participants with symptomatic unilateral cerebrovascular steno-occlusive disease at either the subacute or chronic stroke stage were selected from an ongoing prospective BOLD-CVR database between February 2015 and February 2018. Patients older than 18 years with symptomatic unilateral cerebrovascular steno-occlusive disease treated at University Hospital Zurich who gave informed consent were included in this database. Participants were extracted from this database and included in the study if they had undergone acetazolamide challenged ( 15 O)-H 2 O-PET and BOLD-CVR imaging within a time frame of 4 weeks. Participants with an interval more than 4 weeks between PET and BOLD-CVR imaging were excluded because of potential disease alteration. All enrolled participants underwent the same PET imaging as a reference standard. Other exclusion criteria were signs of cerebellar infarction or other cerebellar pathology on initial or follow-up imaging, new neurologic symptoms between both scans, surgical revascularization between both scans and inability or refusal to sign informed consent.
Image acquisition and processing
BOLD-CVR
MRI data were acquired on a 3-tesla Skyra VD13 (Siemens Healthcare, Erlangen, Germany) with a 32-channel head coil. BOLD fMRI parameters: axial 2-dimensional single-shot echo-planar imaging sequence planned on the anterior commissure-posterior commissure line plus 20°(on a sagittal image), voxel size 3 × 3 × 3 mm . Two hundred volumes were acquired for the CVR study. A 3-dimensional, T1-weighted, magnetization-prepared rapid-acquisition gradient echo image was also acquired with the same orientation as the fMRI scans for overlay purposes. Acquisition parameters were as follows: voxel size 0.8 × 0.8 × 1.0 mm 3 with a field of view 230 × 230 × 176 mm and scan matrix of 288 × 288 × 176, repetition time/echo time/inversion time 2,200/5.14/900 milliseconds, and flip angle 8°. The carbon dioxide stimulus was given with a computer-controlled gas blender with prospective gas targeting algorithms (RespirAct; Thornhill Research Glossary BOLD = blood oxygen level-dependent; CCD = crossed cerebellar diaschisis; CI = confidence interval; CVR = cerebrovascular reactivity; MNI = Montreal Neurological Institute; mRS = modified Rankin Scale; NIHSS = NIH Stroke Scale.
Institute, Toronto, Canada). This stimulus allows for precise targeting of arterial partial pressure of oxygen and carbon dioxide. 15 We controlled the carbon dioxide at the participant's own resting carbon dioxide value. During the CVR study, carbon dioxide was increased approximately 10 mm Hg above their resting carbon dioxide value for 80 seconds. Oxygen was maintained at a level of approximately 100 mm Hg during the entire protocol.
Data preprocessing and BOLD-CVR calculations
All the acquired raw BOLD volumes were transferred and analyzed with SPM 12 (Statistical Parameter Mapping Software; Wellcome Department of Imaging Neuroscience, University College of London, UK). The BOLD volumes were timecorrected and orthogonalized in 6 translational and rotational motion estimates to decrease the influence of head motion. The BOLD volumes were then aligned to the T1-weighted image and normalized in Montreal Neurological Institute (MNI) space of the MNI/ICBM AVG 152 template using a 12-parameter affine linear transformation and warping of the images using a nonlinear transformation. Finally, the BOLD volumes were smoothed with a gaussian kernel with 8-mm full width at half maximum.
The CVR calculations were done according to a previously described and validated method. 16 In short, after temporal shifting for optimal physiologic correlation of the 2 time series, CVR was calculated from the slope of a linear least square fit of the BOLD signal time course to the carbon dioxide time series over the range of the first baseline of 100 seconds, the 80 seconds step portion of the protocol, and the second baseline of 100 seconds on a voxel-by-voxel basis. CVR was defined as the percentage BOLD signal change per mm Hg carbon dioxide change. The extra BOLD volumes were acquired to allow for potential temporal shift. PET data were acquired on a full-ring PET/CT scanner in 3-dimensional mode (PET/CT Discovery STE; GE Healthcare, Waukesha, WI). The images were corrected for attenuation and scatter by using the manufacturer's own algorithms and a corresponding CT (120 kV/80 mA). The total axial field of view was 15.3 cm. Images were reconstructed using a 3-dimensional Fourier rebinning filtered backprojection algorithm giving a 128 × 128 × 47 matrix with 2.34 × 2.34 × 3.27 mm voxel spacing. Over a period of approximately 20 seconds, 300 to 800 MBq of ( 15 O)-H 2 O was administered IV using an automatic injection device. The emission data were acquired as a series of 18, 10-second frames. Acetazolamide was injected approximately 13 minutes before the second PET scan (dose adjusted according to weight) over a period of 2 minutes. Parametric images of cerebral blood flow before and after the acetazolamide challenge were generated using a previously reported method 23, 24 in which a standardized arterial input function and image scaling based on the washout rate k2 of ( 15 O)-H 2 O are used to determine cerebral blood flow. This method 24 utilizes the fact that k2 is related to the shape and not the scale of the arterial input function and proportional to cerebral blood flow. A total count-rate threshold was set at 50% of the maximum.
The baseline PET image and acetazolamide PET image were then coregistered to the mean BOLD to allow for normalization of the images. Similar to the BOLD images, normalization of the 2 PET images was done in MNI space and smoothed with a gaussian kernel with 8-mm full width at half maximum. CCD was determined visually based on PET baseline images by an experienced senior staff member of the Department of Nuclear Medicine (A.B.) who was blinded toward the BOLD-CVR findings. For both the PET cerebral blood flow images and the BOLD-CVR image, a cerebellar asymmetry index (ipsilateral [to supratentorial stroke] cerebellar hemisphere − crossed cerebellar hemisphere/ipsilateral hemisphere) was determined using a predefined cerebellar mask to allow for a quantitative analysis of the visually selected CCD-positive and -negative groups. This cerebellar asymmetry index is reported as a percentage.
Assessment of neurologic and functional status
The NIH Stroke Scale (NIHSS) and modified Rankin Scale (mRS) were used to evaluate the neurologic and functional status at the time of stroke, and at 3-month follow-up.
Statistical analysis
We performed the statistical analysis using SPSS Statistics 23 (IBM Corp., Armonk, NY). First, normal distribution was evaluated using the Shapiro-Wilk test. Means of normally distributed continuous variables from the CCD-positive and CCD-negative groups were compared by an independent Student 2-tailed t test, where p < 0.05 was considered statistically significant. Variables with nonnormal distribution were analyzed using the Mann-Whitney U test. All normally distributed continuous variables are reported as mean ± SD. Categorical ordinal variables are presented as median (interquartile range) whereas dichotomous variables are shown as frequency (%). To evaluate cerebral blood flow reactivity in PET imaging as well as the quantitative intrasubject cerebellar hemisphere CVR differences, we used a paired sample t test. For the assessment of detecting CCD, a receiver operating characteristic curve and the area under the curve were calculated, including a confidence interval (CI). A Bland-Altman analysis was used to compare mean differences in cerebellar asymmetry index between BOLD-CVR and PET baseline imaging, and the results were plotted to evaluate the agreement between the 2 techniques and potential bias.
To identify a relationship between the cerebellar asymmetry index, detected by either BOLD-CVR or one of the PET images, and neurologic outcome after 3 months, measured using NIHSS and mRS, we used a Spearman rank-order correlation analysis.
Data availability
In addition to the detailed methodologic description provided in this report, numeric data of the individual 27 datasets can also be made available in anonymized format. Please contact the corresponding author for such a request.
Results
From the prospective database, 33 participants underwent both ( 15 O)-H 2 O-PET and BOLD-CVR scans resulting in 35 datasets that were considered for inclusion. After evaluation of exclusion criteria, 25 participants were eligible for further analysis. Two participants qualified for inclusion twice. One participant fulfilled the inclusion criteria twice as he experienced 2 ischemic events on separate occasions, while a second participant underwent pre-and postsurgical imaging after extracranial-tointracranial bypass revascularization. Eight patients were excluded because the time period between PET and BOLD-CVR scans exceeded 4 weeks and one patient was excluded because of missed follow-up scans. In total, 27 combined BOLD-CVR and PET studies were performed in 25 participants. Mean age was 57 ± 15 years and 70% of the participants were men. The clinical and relevant baseline characteristics of all participants are shown in tables 1 and 2. Of the 27 datasets, 11 (41%) were classified as CCD positive. None of the 10 participants (11 datasets) with CCD positivity showed clinical signs of cerebellar dysfunction. Two participants from the CCDnegative group and one participant from the CCD-positive group underwent thrombolysis previous to the BOLD and PET scans. Exemplary imaging illustrations of one CCD-positive and one CCD-negative participant are shown in figure 1. The receiver operating characteristic curve and BlandAltman analysis are presented in figure 2 . Here, BOLD-CVR shows an area under the curve of 0.89 (95% CI: 0.75-1.0). This area under the curve of BOLD-CVR was not different from the PET imaging (area under the curve PET cerebellar asymmetry index: 0.94, 95% CI: 0.85-1.0). The receiver operating characteristic curve showed that with a cutoff point of 6% BOLD-CVR cerebellar asymmetry index, CCD could be detected with a sensitivity of 0.91 and a specificity of 0.81. The cutoff points for PET baseline cerebellar asymmetry index and PET Diamox cerebellar asymmetry index were 4.2% and 5.0%, respectively. The Bland-Altman analysis showed a proportional bias when combining data of both groups (r 2 = 0.7, p < 0.001; figure 2B ). Considering the data of the CCD-negative participants alone, a good agreement was found without proportional bias (r 2 = 0.30, p = 0.1; figure 2C ). 
Clinical status and outcome assessments
Discussion
The main finding of our study is that, similar to baseline and acetazolamide challenged ( 15 O)-H 2 O-PET, BOLD-CVR can detect the presence of CCD with high specificity and sensitivity. Furthermore, the presence of CCD corresponds to a poorer neurologic status at baseline and at 3-month followup, a finding in concordance with previous studies.
1,2,25 It is of interest that the cerebellar asymmetry index derived from BOLD-CVR showed a strong positive correlation to NIHSS and mRS stroke severity scores at 3 months.
Others have already reported the feasibility of noninvasive BOLD-CVR as a novel method to study CCD. A recent feasibility study 22 demonstrated that participants with CCD identified with arterial spin labeling (i.e., cerebellar hemispheric cerebral blood flow asymmetry) also had significantly reduced cerebellar hemispheric BOLD-CVR as compared to control participants without cerebral blood flow asymmetry. BOLD asymmetry was also studied by using a hyperoxic gas Figure 1 Example of CCD-positive (A) and CCD-negative (B) participant (A) A 48-year-old man with ischemia in the right middle cerebral artery territory due to a middle cerebral artery occlusion (white x). He presented with left facial palsy, left-sided hemiparesis, and dysphasia (NIHSS 9/42, mRS 4). On PET and BOLD-CVR imaging, clear signs of supratentorial hemodynamic impairment can be seen in right middle cerebral artery territory (white arrow). In his cerebellum, cerebellar asymmetry can be appreciated contralateral to his supratentorial lesion with good spatial agreement between both imaging modalities, i.e., crossed cerebellar diaschisis (white arrow on bottom images). After 3 months, he showed an improvement of his left-sided hemiparesis, facial palsy, and speech (NIHSS 5/42, mRS 2). (B) A 77-year-old man with ischemia in the left paracentral lobule due to a left internal carotid artery occlusion (white x). He presented with a mild sensorimotor paresis of his right leg (NIHSS 2/42, mRS 3), which resolved quickly. The participant did not experience any neurologic symptoms after 3 months (NIHSS 0/42, mRS 0). For both PET imaging as well as BOLD-CVR, supratentorial hemodynamic impairment can be appreciated on the left side (white arrow), whereas no crossed cerebellar diaschisis is observed. BOLD = blood oxygen level-dependent; CCD = crossed cerebellar diaschisis; CVR = cerebrovascular reactivity; DWI = diffusion-weighted imaging; FLAIR = fluidattenuated inversion recovery; mRS = modified Rankin Scale; NIHSS = NIH Stroke Scale.
challenge to show significant asymmetric cerebellar hemispheric BOLD signal changes in a small cohort of participants with acute large-volume middle cerebral artery strokes. 26 Using a novel carbon dioxide application technique 27 and improved BOLD-CVR analysis methods, 16 we were able to generate high-resolution quantitative cerebellar BOLD-CVR maps. With a cutoff point of BOLD-CVR cerebellar asymmetry index of 6, CCD was detected with a sensitivity of 0.91 and a specificity of 0.81.
Significance of CCD detection
Our study found 40.7% of participants with CCD, which is similar to the incidence reported by others. 7, [28] [29] [30] Our data confirm that CCD is related to worse neurologic outcome and for the crossed cerebellar diaschisis-negative cohort alone (C). Note that a proportional bias can be seen when considering data of both groups. For the crossed cerebellar diaschisis-negative cohort alone (C), a good agreement is found. BOLD = blood oxygen level-dependent; CAI = cerebellar asymmetry index; CVR = cerebrovascular reactivity.
after stroke, as compared to previous studies. 1, 2, 4, 25 On the contrary, others 29, 31 have shown that the presence of CCD in the acute phase has no effect on functional outcome. It is important to mention that correction of hypoperfusion after acute-stage stroke could shift some participants from CCD positive to CCD negative. 2 Here, with a PET imaging study, the presence of CCD was assessed at 4 different time points (before thrombolysis, 3 hours, 24 hours, and 14 days later). 2 Here, participants who recovered from CCD tended to have a more favorable outcome.
CCD data interpretation CCD may be caused by an interruption of corticopontocerebellar fiber tracts projecting via pontine nuclei to the contralateral cerebellar cortex and cerebellar nuclei thereby leading to a reduced activation of the cortical Purkinje cells. 32, 33 Conversely, alterations of the reciprocal cerebellothalamocortical tracts may also result in impaired feedback to the cerebrum, resulting in less input from the cerebrum.
The net result is that CCD manifests itself primarily through decreased cerebellar blood flow, oxygen extraction fraction, and cerebral blood volume. 22, 29 In the affected cerebellar hemisphere, the decreased cerebral blood volume and blood flow may occur due to a physiologic vasoconstrictive response to decreased metabolic needs without loss of vasodilatory capacity. Hence, the cerebral blood flow reactivity (i.e., cerebral blood flow change in response to a vasoactive stimulus) remains functional. [34] [35] [36] Our data also showed no difference in PET cerebellar asymmetry index before and after the acetazolamide challenge, thereby confirming a preserved cerebral blood flow reactivity. With a preserved cerebral blood flow reactivity, the reduced cerebellar BOLD-CVR response in participants who are CCD positive may therefore be explained by the presence of hypometabolism. As a consequence, there is, on average, less conversion of oxyhemoglobin into deoxyhemoglobin. Since the BOLD signal primarily depends on the relative change in deoxyhemoglobin (i.e., oxy-/deoxyhemoglobin ratio) before and after a vasoactive stimulus, BOLD-CVR in the crossed cerebellar hemisphere will be dampened, despite intact cerebral blood flow reactivity. Of note, the different methodology between BOLD-CVR and PET imaging may explain the proportional bias. In participants with CCD, the decrease in cerebellar cerebral blood flow seems not to be in similar proportions as the relative change in metabolism.
Further CCD considerations Based on our data and further review of the available literature, we believe that a subdivision of CCD can be proposed. CCD, in some cases, has the potential to regenerate and recover. 2, 37, 38 Why CCD resolves in some cases but persists in others is still an open question. Therefore, the presence of an overall more severely impaired supratentorial CVR in our CCD cohort is a potentially very interesting finding. Since not only larger infarctions, but on average overall larger supratentorial hemodynamic impairment is seen in participants with CCD, 2, 29 we postulate that CCD not only occurs in case of direct damage to the corticopontine cerebellar fiber tracts, but that severe acute or chronic supratentorial hemodynamic impairment may also induce CCD. It is known that hemodynamic impairment, in absence of acute stroke, can alter brain structure and function 39, 40 -for instance, the theory of a "hibernating brain concept" in patients with chronic stroke. 40 This concept postulates the decrease of cortical excitability and increase in resting motor threshold, in case of a misery cerebral perfusion (impaired or negative CVR). Of note, after revascularization, these participants showed an increase in cortical excitability and a decrease in motor resting threshold with alleviation of misery perfusion. 40 This would explain why recovery of CCD is seen in participants with small infarcts after reperfusion with thrombolysis 2 and CCD is even found in stenoocclusive disease participants with misery perfusion but without radiologically defined stroke lesions. 41 From our point of view, we believe a pathophysiologic distinction needs to be made between lesion-induced and hemodynamic-induced CCD, especially as the current definition of CCD still requires the presence of a supratentorial lesion. We will further study this hypothesis in a larger CCD cohort.
Limitations
Our data must be interpreted in the context of the study design. First, the study cohort was small (i.e., 27 datasets from 25 participants), but in concordance with other CCD studies. 1, 2, 8 Although our study consisted of a uniform participant population (i.e., those with unilateral steno-occlusive disease), the BOLD-CVR study was performed at either the subacute or chronic stroke stage with a wide range from 1 week to 79 months. Moreover, we cannot comment on acute stroke findings in this participant group. Similarly, as seen in another recent BOLD-CVR study, 22 the cerebral blood flow asymmetry values used to define CCD were based on a region covering a large portion of the cerebellum. Our findings show that hypoperfusion and decreased BOLD signal are not present for the whole cerebellar hemisphere (as can be seen in figure 1A) . A more detailed analysis of cerebellar anatomical and functional areas may therefore be considered in future work.
Conclusions
The main finding of our study is that BOLD-CVR demonstrates similar sensitivity to detect CCD as compared to ( 15 O)-H 2 O-PET in patients with symptomatic unilateral cerebrovascular steno-occlusive disease. Furthermore, CCD-positive participants had a poorer baseline neurologic performance and neurologic outcome at 3 months. Of interest, a larger BOLD-CVR cerebellar asymmetry index showed good agreement to worse performance on the NIHSS and mRS scales at 3 months. This agreement was not found for the PET cerebellar asymmetry index.
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